Mid-period crossings: the quarter's story is things that started during it and are still completing
The model's full reasoning — Q3 2021 call → NOThe question asks whether management's account of the just-reported period is built substantially around real business activity that crossed from not-happening to happening partway through the period or just around its edges, and whether management makes clear that this newly started activity is still completing its climb, so the period's reported numbers averaged the 'before' and 'after' and therefore sit below the level at which the business is already running. Let me examine the transcript for evidence of both halves: (1) THE PERIOD CONTAINED REAL STARTS, NARRATED AS STARTS. Management describes one or more concrete pieces of business that genuinely BEGAN during or immediately around the reported period. Looking at the transcript, what starts are mentioned? - XenoSure CE Mark issues resolved in Q3, and Japanese launch showed momentum. The CE Mark was obtained in Q2, and Q3 was when they finally had sellable products. J.J. says: "It has a lot to do with the resolution of the CE issues around XenoSure, going from Q2 when we got the CE mark to Q3 when we finally had sellable products." This is a start - the product became sellable in Q3. - The sales force expansion: 103 reps on payroll, 6 more offers signed, 17 more territories being recruited. But this is hiring, not yet transacting business. - The $20 minimum wage and increased entry-level sales rep pay - these are changes to enable hiring, not business starts. - Artegraft acquisition was in June 2020, so that's not new. - The XenoSure CE resolution and Japanese launch - the CE mark was obtained in Q2, and Q3 was when they had sellable products. This is a genuine start - product became sellable and they had record bovine carotid patch sales. J.J. says: "That was a record bovine carotid patch quarter. It's notable. It didn't make it to the top three product lines, but in and of itself it was a record quarter. It has a lot to do with the resolution of the CE issues around XenoSure, going from Q2 when we got the CE mark to Q3 when we finally had sellable products. There are as of a week ago, there are no back orders on XenoSure at the company right now." So XenoSure became sellable in Q3 - that's a real start. The CE mark was obtained in Q2, and Q3 was when they had sellable products. This is a genuine start of transacting business. (2) THE CLIMB IS INCOMPLETE AND THE PRINTED NUMBERS LAG IT.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| AIN | Albany International Corp. | Q3 2023 | 2023-11-07 | B |
| AFL | Aflac Incorporated | Q2 2023 | 2023-08-02 | C+ |
| CARS | Cars.com Inc. | Q1 2023 | 2023-05-06 | B |
| HLX | Helix Energy Solutions Group, Inc. | Q1 2018 | 2018-04-24 | B+ |
| SBSI | Southside Bancshares, Inc. | Q4 2017 | 2018-02-06 | A |
| ANIP | ANI Pharmaceuticals, Inc. | Q4 2016 | 2017-03-02 | B+ |
| PSX | Phillips 66 | Q4 2016 | 2017-02-03 | C+ |
| ESE | ESCO Technologies Inc. | Q2 2016 | 2016-05-03 | A |
AFL · Q2 2023 → YESThe question is about whether management's account of the just-reported period is built around real business activity that started partway through the period, and that the numbers average before and a...YES The transcript shows management's account centered on the Japan Post cancer insurance launch in early April, which began selling the product and drove a 60% sales increase as a major contributor. They describe the activity as real and transacting, with Dan Amos noting the significant contribution from the new product. Yoshizumi confirms gradual increase going forward, and Fred highlights runway for more agents and sales calming down after initial jump, indicating the Q2 numbers reflect partial ramp-up rather than full run-rate.
ESE · Q2 2016 → YESThe question is about whether management's account of the just-reported period is built around real business activity that started partway through the period, and that the numbers average before and a...YES The transcript shows management's account centered on the real mid-period start of Plastique's contribution (acquired partway through Q2, with two months of performance noted and "early performance consistent with our acquisition forecast"), treated as a key new segment. It also explicitly addresses the incomplete climb, noting that the reported Q 2 numbers lag due to partial contribution and that Q3/Q4 will see fuller periods plus seasonality, with the business already running at a higher level as the ramp continues.
PSX · Q4 2016 → YESThe question is about whether management's account of the just-reported period is built substantially around real business activity that crossed from not-happening to happening partway through the per...YES The transcript shows management centering the Q4 story on the Freeport LPG Export Terminal's real start: commissioning completed smoothly, first commercial cargo shipped mid-December (partial Q4 contribution), with full-quarter costs incurred but only partial revenue, and explicit ramp to near-capacity loading in January onward.